Viewing Study NCT01060059


Ignite Creation Date: 2025-12-24 @ 2:31 PM
Ignite Modification Date: 2026-01-29 @ 3:51 PM
Study NCT ID: NCT01060059
Status: COMPLETED
Last Update Posted: 2015-04-09
First Post: 2010-01-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetes; exenatide; Byetta; basal insulin; Amylin; Lilly View